Quantcast

Latest Dominion Diagnostics Stories

2014-09-30 08:32:25

NORTH KINGSTOWN, R.I., Sept. 30, 2014 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and actionable clinical information, now offers a new laboratory?based urine test for the detection of commonly prescribed Z?Drugs. http://photos.prnewswire.com/prnvar/20140204/NE57628LOGO "Z?Drugs" are a class of non?benzodiazepine medications prescribed mainly for the treatment of insomnia. Included in this group are zolpidem (Ambien®),...

2014-04-22 08:34:43

NORTH KINGSTOWN, R.I., April 22, 2014 /PRNewswire/ -- Kenneth Blum, PhD, President and CEO of IGENE, LLC, has long been associated with leading drug monitoring laboratory Dominion Diagnostics in a scientific research and advisory role. Blum, who sits on Dominion's Addiction and Scientific Advisory Board, was recently appointed Chief Scientific Advisor to Dominion Diagnostics. At the 2014 American Society of Addiction Medicine (ASAM) Annual Medical-Scientific Conference in Orlando,...

2014-02-04 12:27:29

NORTH KINGSTOWN, R.I., Feb. 4, 2014 /PRNewswire/ -- Dominion Diagnostics is pleased to announce its renewed commitment to support education and advancement in addiction medicine and behavioral healthcare. For its second consecutive year, Dominion is the Series Thought Leadership Partner for the 2014 Addiction Professional Panel Series hosted by Vendome Healthcare Media. (Logo: http://photos.prnewswire.com/prnh/20140204/NE57628LOGO) The 2014 Panel Series will consist of...

2010-12-20 10:00:00

NORTH KINGSTOWN, R.I. and BOSTON, Dec. 20, 2010 /PRNewswire/ -- Riverside Partners, a Boston-based private equity firm, is pleased to announce that it has made a majority equity investment in Dominion Diagnostics ("Dominion"), a leading laboratory services company focused on quantitative testing to support patient medication monitoring. The investment was completed in partnership with the founders and management of the business. Founded in 1997, Dominion is a premier provider of...

2010-09-20 07:00:00

NORTH KINGSTOWN, R.I., Sept. 20 /PRNewswire/ -- Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products. Users looking for a "legal high" have reportedly turned to these products as an alternative to marijuana. Two compounds, JWH-018 and JWH-073, have been identified in...

2010-06-15 08:00:00

NORTH KINGSTOWN, R.I., June 15 /PRNewswire/ -- At the forefront of the ongoing effort to enhance addiction treatment outcomes, one leading Rhode Island Company has announced the next-generation clinical laboratory diagnostics tool designed to assist clinicians. Dominion Diagnostics (Dominion), a privately-held clinical urine drug testing laboratory, today announced the release of its new Comprehensive Analysis of Reported Drugs (CARD)(TM) results, a unique clinical laboratory reporting...

2010-04-15 10:35:00

NORTH KINGSTOWN, R.I., April 15 /PRNewswire/ -- Unintentional poisoning deaths have dramatically increased over the last decade to become the second leading cause of injury deaths in the United States. Along with this trend, the number of Emergency Room visits and resulting hospitalizations has also increased. According to a recent study conducted by the West Virginia School of Medicine, hospitalizations for poisonings from overdoses of prescription opioids, sedatives and tranquilizers...

2009-10-07 10:24:00

NORTH KINGSTOWN, R.I., Oct. 7 /PRNewswire/ -- Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test. For its pain management clients, Dominion has refined its laboratory testing procedure for the opioid medication fentanyl. Dominion has now lowered the limit of quantification (LOQ) for the primary metabolite, norfentanyl, to 1 ng/mL....

2009-09-14 11:39:00

NORTH KINGSTOWN, R.I., Sept. 14 /PRNewswire/ -- Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management....


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related